Article
[Etravirine: genetic barrier and resistance development].
Enfermedades infecciosas y microbiologia clinica - 1 Dec 2009
Llibre Josep M, Santos José Ramón, Clotet Bonaventura
Abstract excerpt
Unlike first-generation non-nucleoside reverse transcriptase inhibitors (NNRTI), to develop complete resistance to etravirine (ETR), various mutations must be accumulated. This drug shows an intermediate barrier against partial resistance and a high barrier to complete resistance. Some mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
